- Resources for Journalists
- Join us
EU heads of state and government failed to agree on a united response to the economic crisis triggered by COVID-19. Yet after the measures taken by the European Central Bank, there is no longer urgency to enact a measure like eurobonds.
The COVID-19 outbreak has revived fears over acute drug shortages in Europe, sparking calls to repatriate the production of pharmaceutical ingredients from China. But rebuilding capacity would take years, if it were even possible.
How prepared are European hospitals to manage a steep increase of intensive care hospitalizations, needed in severe cases of coronavirus syndrome? We have collected some data, but the picture is far from complete.
Since the data available on the coronavirus pandemic is patchy and incomplete, it needs to be approached with caution and an awareness of what it can – and cannot – tell us about the deadly virus.
Calls have been coming from all sides for the EU to intervene in the COVID-19 crisis in the name of European solidarity. Although the Union has little room for manoeuvre in the public-health sphere, it can use the powerful lever of economic and monetary policy to counter the coming economic downturn.